Veradermics, Incorporated MANE 深 滬
已收盤 05-08 16:00:00 美东时间
106.14
-1.710
-1.59%
華盛通- 最 高110.7925
- 今 開107.88
- 成交量 49.64万股
- 最 低 105.225
- 昨 收 107.85
- 總市值 43.71亿
- 52周最高 117.71
- 市盈率 靜 --
- 換手率 1.21%
- 52周最低 32.00
- 委 比 24.81%
- 總股本 4118.33万
- 歷史最高 117.71
- 量 比 0.57
- 振 幅 5.16%
- 歷史最低 32.00
- 每 手 1
- 風險率 20.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | 净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%
累计净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%，Q1营收同比翻倍大超预期>>
05-04 18:33
Veradermics Boosts Capital Through Public Offering and Warrants
Veradermics, Incorporated ( ($MANE) ) has shared an announcement. On May 1, 202...
05-02 05:52
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Caterpillar, Textron and Wesco International, on Friday. HIGHLIGHTS * Arrowhead Pharmaceuticals ARWR.
05-01 15:29
30年来首个！美国口服脱发新药临床大胜：2个月长出新头发
（来源：求实药社） 4月28日，一家名不见经传开发脱发药的Biotech公司Veradermics（NYSE: MANE）暴涨。 暴涨源自MANE旗下的米诺地...
04-30 12:04
Veradermics sells $30 million pre-funded warrants in unregistered private placement
Veradermics sells $30 million pre-funded warrants in unregistered private placement Veradermics priced private placement of 300,000 pre-funded warrants to entities affiliated with Suvretta Capital. Warrants priced at USD 100 per share less USD 0.00001 exercise price. Gross proceeds expected at about
04-30 10:46
美股牛股 | 转型锂资源运输！海纳天成国际飙升近240%；X-Energy上市次日续涨超23%
转型锂资源运输！海纳天成国际飙升近240%；X-Energy上市次日续涨超23%，获亚马逊、ARK等明星机构支持>>
04-28 15:42
Veradermics announces launch of public offering
Veradermics (MANE) on Monday announced that it has launched a proposed public offering of 3.35M shares of common stock. All of the shares and pre-funded warrants are being offered by Veradermics. In a...
04-28 05:48
Veradermics Reports Phase 2/3 Data For VDPHL01; Shows Significant Hair Growth Gains (30-33 hairs/cm²) And Strong Efficacy Vs Placebo In Pattern Hair Loss Treatment
VDPHL01, a novel orally-administered extended-release minoxidil formulation, met all primary and all key secondary endpoints with high statistical significance in both active treatment arms evaluating once-daily (QD) and
04-27 21:24
美股大行评级 | 巴克莱大幅上调希捷科技、西部数据目标价！联合健康、霍顿房屋、盈透证券、奎斯特诊疗等获多家机构上调目标价
今日重点评级关注：Piper Sandler：维持MeiraGTx Holdings"超配"评级，目标价从26美元升至30美元；康托·菲茨杰拉德：维持MKS Inc."超配"评级，目标价从300美元升至400美元
04-23 12:35
Leerink Partners Maintains Outperform on Veradermics, Raises Price Target to $90
Leerink Partners analyst Marc Goodman maintains Veradermics (NYSE:MANE) with a Outperform and raises the price target from $75 to $90.
04-22 22:09
